Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 01, 2019

SELL
$29.93 - $36.8 $706,707 - $868,921
-23,612 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$27.65 - $31.68 $63,677 - $72,959
-2,303 Reduced 8.89%
23,612 $748,000
Q1 2019

May 07, 2019

SELL
$26.79 - $31.72 $28,129 - $33,306
-1,050 Reduced 3.89%
25,915 $775,000
Q4 2018

Feb 13, 2019

SELL
$29.28 - $41.29 $205,340 - $289,566
-7,013 Reduced 20.64%
26,965 $833,000
Q3 2018

Nov 13, 2018

BUY
$34.44 - $39.35 $1.17 Million - $1.34 Million
33,978 New
33,978 $1.29 Million

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.91B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.